https://www.sciencedaily.com/news/health_medicine/pharmacology/ Drug discovery. Read the latest in new drug development and pharmacology from leading research institutes around the world. en-us Mon, 08 Jun 2026 22:11:13 EDT Mon, 08 Jun 2026 22:11:13 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/pharmacology/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/06/260608035959.htm Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process inside brain cells. In mice, the treatment slowed nerve cell loss, reduced Alzheimer’s-related changes, and even appeared to promote healthier aging. Mon, 08 Jun 2026 19:23:33 EDT https://www.sciencedaily.com/releases/2026/06/260608035959.htm https://www.sciencedaily.com/releases/2026/06/260606015144.htm A traditional Chinese medicinal root used for over a thousand years is attracting new scientific attention for its potential to combat hair loss. Studies suggest Polygonum multiflorum can block harmful hormones, activate hair-growth signals, protect follicles, and boost blood flow to the scalp. Researchers say the herb’s effects align remarkably well with both ancient descriptions and modern hair biology. Sun, 07 Jun 2026 04:19:08 EDT https://www.sciencedaily.com/releases/2026/06/260606015144.htm https://www.sciencedaily.com/releases/2026/06/260605023417.htm Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications. Fri, 05 Jun 2026 11:13:02 EDT https://www.sciencedaily.com/releases/2026/06/260605023417.htm https://www.sciencedaily.com/releases/2026/06/260605023408.htm Supplements are often marketed as shortcuts to better health, but for many older adults, the real issue is whether they have a specific deficiency. Vitamins like B12 and D can play an important role when levels are low, while protein may be one of the most overlooked nutrients for maintaining strength and independence. More isn’t always better, though—some supplements can cause harm or interact with medications. Sat, 06 Jun 2026 08:40:28 EDT https://www.sciencedaily.com/releases/2026/06/260605023408.htm https://www.sciencedaily.com/releases/2026/06/260605023400.htm A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical trials are now being planned to test whether these drugs could help prevent breast cancer. Sat, 06 Jun 2026 09:28:24 EDT https://www.sciencedaily.com/releases/2026/06/260605023400.htm https://www.sciencedaily.com/releases/2026/06/260604044247.htm For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn't be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced disease and reduced the risk of death by 60%. Thu, 04 Jun 2026 09:18:44 EDT https://www.sciencedaily.com/releases/2026/06/260604044247.htm https://www.sciencedaily.com/releases/2026/06/260603023919.htm A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths. Wed, 03 Jun 2026 10:04:58 EDT https://www.sciencedaily.com/releases/2026/06/260603023919.htm https://www.sciencedaily.com/releases/2026/06/260603015541.htm Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like Ozempic. Rather than reducing hunger, it activates metabolism in skeletal muscle, helping lower blood sugar and increase fat burning while preserving muscle mass. Early clinical results suggest the treatment is safe and well tolerated. Wed, 03 Jun 2026 09:27:40 EDT https://www.sciencedaily.com/releases/2026/06/260603015541.htm https://www.sciencedaily.com/releases/2026/06/260602021645.htm A major study suggests that some of the groundwork for brain development may be shaped before birth through a surprising partnership between a baby’s genes and gut microbes. Researchers found that epigenetic changes present at birth can influence how the gut microbiome develops during the first year of life, and certain combinations were linked to early signs of autism and ADHD by age three. Tue, 02 Jun 2026 10:18:47 EDT https://www.sciencedaily.com/releases/2026/06/260602021645.htm https://www.sciencedaily.com/releases/2026/05/260530053429.htm A Salk Institute study found that a simple dietary amino acid, methionine, dramatically improved survival in mice facing severe infections and inflammatory conditions. Rather than directly targeting the immune system, methionine boosted kidney filtration, helping the body flush out excess inflammatory molecules that can cause tissue damage, brain dysfunction, wasting, and death. Mon, 01 Jun 2026 09:44:52 EDT https://www.sciencedaily.com/releases/2026/05/260530053429.htm https://www.sciencedaily.com/releases/2026/05/260530053426.htm A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk. Researchers found that just one year of treatment with the immune-targeting drug abatacept delayed the onset of rheumatoid arthritis by up to four years, with benefits lasting long after treatment ended. Mon, 01 Jun 2026 09:25:47 EDT https://www.sciencedaily.com/releases/2026/05/260530053426.htm https://www.sciencedaily.com/releases/2026/05/260530004626.htm A new study suggests fish oil may help reduce insulin resistance even in people who aren't obese. In diabetic rats, omega-3 supplementation improved blood sugar levels, cholesterol, and inflammation by shifting immune cells into a more anti-inflammatory mode. Sun, 31 May 2026 01:15:13 EDT https://www.sciencedaily.com/releases/2026/05/260530004626.htm https://www.sciencedaily.com/releases/2026/05/260529043644.htm A specially formulated tomato-soy juice packed with natural plant compounds may help calm inflammation linked to obesity, according to a new clinical study. Healthy adults with obesity who drank the juice daily for four weeks saw significant reductions in several key inflammatory proteins in their blood, while a control tomato juice did not produce the same effect. Sat, 30 May 2026 01:53:49 EDT https://www.sciencedaily.com/releases/2026/05/260529043644.htm https://www.sciencedaily.com/releases/2026/05/260527023204.htm A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life. Thu, 28 May 2026 00:42:54 EDT https://www.sciencedaily.com/releases/2026/05/260527023204.htm https://www.sciencedaily.com/releases/2026/05/260527023200.htm Researchers found that drinking guava juice may significantly improve anemia by helping the body absorb iron more efficiently. In a review of 17 studies, women and teenage girls who consumed guava juice — especially with iron supplements — experienced noticeable increases in hemoglobin levels. Since guava contains far more vitamin C than oranges, scientists believe it could become a simple, affordable nutrition tool in regions where anemia is widespread. Wed, 27 May 2026 03:09:36 EDT https://www.sciencedaily.com/releases/2026/05/260527023200.htm https://www.sciencedaily.com/releases/2026/05/260526233632.htm Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease affecting millions worldwide. The experimental drug, ION224, blocks a liver enzyme that drives fat buildup and inflammation, two key forces behind liver damage. In clinical trials, patients showed striking improvements in liver health, even without losing weight. Wed, 27 May 2026 08:49:37 EDT https://www.sciencedaily.com/releases/2026/05/260526233632.htm https://www.sciencedaily.com/releases/2026/05/260526233433.htm Scientists in Japan have created powerful new vitamin K-based compounds that may help the brain regenerate lost neurons — a breakthrough that could one day change how diseases like Alzheimer’s and Parkinson’s are treated. By combining vitamin K with components related to vitamin A, the researchers developed compounds that were about three times more effective at turning neural stem cells into neurons than natural vitamin K alone. Wed, 27 May 2026 00:02:46 EDT https://www.sciencedaily.com/releases/2026/05/260526233433.htm https://www.sciencedaily.com/releases/2026/05/260526022024.htm A drug combo widely explored for anti-aging may actually damage the brain, according to new mouse research showing severe loss of myelin and changes linked to “chemo brain.” Surprisingly, the damaged cells resembled those seen in multiple sclerosis, giving scientists a new lead in understanding—and potentially repairing—the disease. Wed, 27 May 2026 08:23:03 EDT https://www.sciencedaily.com/releases/2026/05/260526022024.htm https://www.sciencedaily.com/releases/2026/05/260525000504.htm USC researchers have identified potential new drug compounds that may reduce the brain inflammation linked to Alzheimer’s disease, especially in people with the high-risk APOE4 gene. The compounds target cPLA2, an enzyme that seems to fuel harmful inflammation while also being important for normal brain activity. Tue, 26 May 2026 00:56:55 EDT https://www.sciencedaily.com/releases/2026/05/260525000504.htm https://www.sciencedaily.com/releases/2026/05/260524021154.htm Drinking nitrate-rich beetroot juice may do more than support heart health — it could actually reshape the bacteria living in the mouth in ways that help lower blood pressure in older adults. In the largest study of its kind, researchers found that older people who drank concentrated beetroot juice twice daily for two weeks experienced noticeable blood pressure reductions, while younger adults did not. Mon, 25 May 2026 01:01:09 EDT https://www.sciencedaily.com/releases/2026/05/260524021154.htm https://www.sciencedaily.com/releases/2026/05/260524021151.htm A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for patients whose heart function remained normal, despite being given to millions worldwide. Even more surprising, women taking the drugs faced a higher risk of death, repeat heart attack, or hospitalization for heart failure compared to women who didn’t receive them. Mon, 25 May 2026 08:36:20 EDT https://www.sciencedaily.com/releases/2026/05/260524021151.htm https://www.sciencedaily.com/releases/2026/05/260524020950.htm Researchers found that adding bananas to berry smoothies can dramatically reduce the body’s ability to absorb healthy flavanols. The surprising discovery shows that even simple food combinations can change how much nutrition your body actually gets. Sun, 24 May 2026 08:48:32 EDT https://www.sciencedaily.com/releases/2026/05/260524020950.htm https://www.sciencedaily.com/releases/2026/05/260523103950.htm For millions battling chronic nerve pain, even the softest touch can feel agonizing — but scientists may have uncovered a radically new way to stop it at the source. Researchers at Duke University found that damaged nerves can be revived by supplying them with healthy mitochondria, the tiny energy producers inside cells. Sun, 24 May 2026 07:51:53 EDT https://www.sciencedaily.com/releases/2026/05/260523103950.htm https://www.sciencedaily.com/releases/2026/05/260523103914.htm By analyzing over 400,000 Reddit posts, researchers discovered that users of popular GLP-1 weight-loss drugs frequently discussed unexpected symptoms like menstrual irregularities, chills, and hot flashes. The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss. Sun, 24 May 2026 07:30:31 EDT https://www.sciencedaily.com/releases/2026/05/260523103914.htm https://www.sciencedaily.com/releases/2026/05/260522031135.htm A surprisingly simple walking tweak may offer new hope for millions living with knee osteoarthritis. In a year-long clinical trial, researchers found that slightly changing the angle of a person’s foot while walking reduced knee pain as effectively as common medications — and even slowed cartilage damage inside the joint. Fri, 22 May 2026 07:07:58 EDT https://www.sciencedaily.com/releases/2026/05/260522031135.htm https://www.sciencedaily.com/releases/2026/05/260522023134.htm A new analysis is raising concerns about Wegovy, the blockbuster weight-loss drug, after researchers found it may carry the highest risk of a rare “eye stroke” that can cause sudden vision loss. The study, based on millions of FDA side-effect reports, found the risk signal was nearly five times stronger for Wegovy than for Ozempic, despite both containing semaglutide. Sat, 23 May 2026 09:23:30 EDT https://www.sciencedaily.com/releases/2026/05/260522023134.htm https://www.sciencedaily.com/releases/2026/05/260521072408.htm Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment. Fri, 22 May 2026 02:12:43 EDT https://www.sciencedaily.com/releases/2026/05/260521072408.htm https://www.sciencedaily.com/releases/2026/05/260521072402.htm Scientists are uncovering a surprising truth about aging cells: some may damage the body, while others help protect it. The discovery is fueling a new wave of precision anti-aging therapies aimed at removing only the harmful “zombie” cells without disrupting the body’s natural repair systems. Fri, 22 May 2026 00:28:12 EDT https://www.sciencedaily.com/releases/2026/05/260521072402.htm https://www.sciencedaily.com/releases/2026/05/260520093731.htm A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes. Thu, 21 May 2026 09:02:24 EDT https://www.sciencedaily.com/releases/2026/05/260520093731.htm https://www.sciencedaily.com/releases/2026/05/260519224334.htm A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers found that removing it from neurons sharply reduced amyloid plaques and improved key brain processes linked to resilience and communication between cells. The discovery may lead to future treatments that go beyond slowing Alzheimer’s — potentially helping protect the brain from further decline. Wed, 20 May 2026 08:54:32 EDT https://www.sciencedaily.com/releases/2026/05/260519224334.htm https://www.sciencedaily.com/releases/2026/05/260519224308.htm Low vitamin D levels could be quietly making breast cancer surgery recovery far more painful. In a new study, patients deficient in vitamin D were three times more likely to experience moderate to severe pain after mastectomy surgery and ended up using significantly more opioid medication to cope. Researchers say vitamin D may help regulate how the body processes pain through its effects on inflammation and the immune system. Tue, 19 May 2026 23:30:39 EDT https://www.sciencedaily.com/releases/2026/05/260519224308.htm https://www.sciencedaily.com/releases/2026/05/260517030515.htm Studies suggest watermelon could be a hidden powerhouse for better health. Researchers found that people who eat watermelon tend to have higher-quality diets packed with more vitamins, fiber, and antioxidants — while consuming less added sugar and saturated fat. Another study showed watermelon juice may help protect blood vessel function and support heart health. Sun, 17 May 2026 08:56:21 EDT https://www.sciencedaily.com/releases/2026/05/260517030515.htm https://www.sciencedaily.com/releases/2026/05/260517030326.htm A new nanotechnology treatment reversed Alzheimer’s symptoms in mice by restoring the brain’s natural cleanup system. The specially engineered nanoparticles helped clear toxic amyloid proteins from the brain and repair the blood-brain barrier, which normally protects and regulates the brain’s environment. In one striking experiment, elderly mice treated with the therapy later behaved like healthy younger mice. Sun, 17 May 2026 07:11:34 EDT https://www.sciencedaily.com/releases/2026/05/260517030326.htm https://www.sciencedaily.com/releases/2026/05/260515002201.htm Cannabis use among older adults is rising fast, but today’s marijuana is far more potent than many people realize — and experts warn the risks may be underestimated. Stanford Medicine specialists say modern cannabis can increase the chances of heart problems, falls, memory issues, dangerous drug interactions, and even addiction, especially for people over 65. Fri, 15 May 2026 08:18:42 EDT https://www.sciencedaily.com/releases/2026/05/260515002201.htm https://www.sciencedaily.com/releases/2026/05/260515002155.htm Scientists have uncovered evidence that serotonin — the same brain chemical boosted by many antidepressants — may actually worsen tinnitus. Using advanced light-based brain stimulation in mice, researchers identified a serotonin-driven circuit linked directly to tinnitus-like behavior. The findings may explain why some people experience louder ringing in their ears while taking SSRIs. Fri, 15 May 2026 07:11:38 EDT https://www.sciencedaily.com/releases/2026/05/260515002155.htm https://www.sciencedaily.com/releases/2026/05/260515002146.htm Scientists are uncovering a surprising link between hidden tooth infections and blood sugar problems. Deep infections around tooth roots can create chronic inflammation that spreads through the body and may interfere with insulin function. Studies found that people who underwent root canal treatment often experienced better blood sugar control and reduced inflammation afterward. The research suggests that treating an infected tooth could have benefits far beyond the mouth. Fri, 15 May 2026 00:21:46 EDT https://www.sciencedaily.com/releases/2026/05/260515002146.htm https://www.sciencedaily.com/releases/2026/05/260512213836.htm Scientists at UBC Okanagan have uncovered how plants produce mitraphylline, a rare natural compound with promising anti cancer potential. The team identified two enzymes that work together to build the molecule’s unusual twisted structure, solving a mystery that had puzzled researchers for years. Because mitraphylline appears only in tiny amounts in tropical plants like kratom and cat’s claw, the discovery could make it far easier to produce sustainably in the future. Tue, 12 May 2026 21:45:40 EDT https://www.sciencedaily.com/releases/2026/05/260512213836.htm https://www.sciencedaily.com/releases/2026/05/260512202350.htm A huge long-term study found that drinking two to three cups of coffee a day was linked to a much lower risk of dementia, especially before age 75. Researchers say caffeine may help keep brain cells active while reducing inflammation and harmful plaque buildup associated with Alzheimer’s disease. But more coffee wasn’t better — the protective effect appeared to level off after moderate intake. Tue, 12 May 2026 20:23:50 EDT https://www.sciencedaily.com/releases/2026/05/260512202350.htm https://www.sciencedaily.com/releases/2026/05/260512202325.htm UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. These compounds activated key serotonin receptors tied to brain plasticity and mental health benefits, but surprisingly did not cause hallucination-like behavior in animal tests. Scientists say the discovery could lead to future treatments for depression, PTSD, and addiction without the intense psychedelic experience. Wed, 13 May 2026 21:07:03 EDT https://www.sciencedaily.com/releases/2026/05/260512202325.htm https://www.sciencedaily.com/releases/2026/05/260511213141.htm Scientists at McGill University have uncovered a hidden molecular “switch” that turns on a powerful calorie-burning system in brown fat — the body’s heat-generating fat linked to metabolism and weight control. The breakthrough centers on glycerol, a molecule released when fat is broken down in the cold, which activates an enzyme called TNAP and triggers an alternative heat-producing pathway that scientists had struggled to explain for years. Tue, 12 May 2026 07:58:13 EDT https://www.sciencedaily.com/releases/2026/05/260511213141.htm https://www.sciencedaily.com/releases/2026/05/260509210646.htm Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These senescent cells survive by relying on a protective protein called GPX4, even while sitting on the edge of a deadly iron-triggered collapse. New drugs remove that protection, causing the cells to self-destruct. In mice, the approach reduced tumor size and boosted survival, hinting at a promising new cancer therapy. Tue, 12 May 2026 21:22:09 EDT https://www.sciencedaily.com/releases/2026/05/260509210646.htm https://www.sciencedaily.com/releases/2026/05/260508171123.htm Scientists have uncovered a surprising secret hidden inside fat cells that could reshape how we think about obesity and metabolic disease. A protein called HSL, long believed to simply release stored fat when the body needs energy, turns out to have a second job deep inside the nucleus of fat cells—helping keep those cells healthy and balanced. Even more surprising, people and mice missing this protein don’t become obese as expected; instead, they lose fat tissue in a dangerous condition called lipodystrophy. Fri, 08 May 2026 17:21:20 EDT https://www.sciencedaily.com/releases/2026/05/260508171123.htm https://www.sciencedaily.com/releases/2026/05/260508024740.htm A common constipation drug may have unexpectedly unlocked a new way to slow chronic kidney disease — a condition that affects millions and often leads to dialysis. In a clinical trial involving 150 patients, researchers found that lubiprostone, a medication normally used to treat constipation, helped preserve kidney function in people with moderate CKD. Scientists traced the effect to changes in gut bacteria that boosted production of spermidine, a compound linked to healthier mitochondria and reduced kidney damage. Fri, 08 May 2026 06:44:49 EDT https://www.sciencedaily.com/releases/2026/05/260508024740.htm https://www.sciencedaily.com/releases/2026/05/260508024125.htm Scientists have uncovered a surprising way to influence the bacteria living in our mouths — not by killing them, but by interrupting how they “talk” to each other. Researchers found that dental plaque bacteria use chemical signals to coordinate growth, and by blocking those signals, they were able to encourage healthier bacteria while reducing disease-linked microbes tied to gum disease. Even more intriguing, the bacterial conversations changed depending on oxygen levels above and below the gums, revealing an entirely new layer of complexity inside the mouth. Fri, 08 May 2026 05:27:16 EDT https://www.sciencedaily.com/releases/2026/05/260508024125.htm https://www.sciencedaily.com/releases/2026/05/260508003127.htm Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are discovered. After testing thousands of compounds, they identified glycyrrhizin — a natural substance found in black licorice — as a promising anti-inflammatory candidate. In both lab-grown tissue and mice, the compound reduced intestinal damage and cell death linked to IBD. Sat, 09 May 2026 20:58:55 EDT https://www.sciencedaily.com/releases/2026/05/260508003127.htm https://www.sciencedaily.com/releases/2026/05/260506225428.htm Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a powerful metabolic enhancer directly into target cells. In mice, it outperformed existing treatments—curbing appetite, increasing weight loss, and improving blood sugar levels. Because the extra drug acts only where it’s needed, it can be used at much lower doses, potentially reducing side effects. Thu, 07 May 2026 06:37:46 EDT https://www.sciencedaily.com/releases/2026/05/260506225428.htm https://www.sciencedaily.com/releases/2026/05/260506225217.htm A little-known tree from Brazil’s Atlantic Forest may hold a surprising weapon against COVID-19. Researchers discovered that compounds called galloylquinic acids, extracted from its leaves, can attack SARS-CoV-2 on multiple fronts—blocking the virus from entering cells, disrupting its replication, and even dampening harmful inflammation. Unlike many antivirals that target just one part of the virus, these natural compounds act in several ways at once, potentially making it harder for resistance to develop. Thu, 07 May 2026 21:39:59 EDT https://www.sciencedaily.com/releases/2026/05/260506225217.htm https://www.sciencedaily.com/releases/2026/05/260505234603.htm A major 10-year clinical trial is turning one of the world’s most common knee surgeries on its head. Researchers found that trimming a damaged meniscus—a procedure long believed to relieve pain—offers no real benefit over placebo surgery. Even more surprising, patients who had the operation actually fared worse over time, with more symptoms, poorer function, faster progression of osteoarthritis, and a greater likelihood of needing additional surgery. Wed, 06 May 2026 01:54:27 EDT https://www.sciencedaily.com/releases/2026/05/260505234603.htm https://www.sciencedaily.com/releases/2026/05/260504211842.htm Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue from within, reducing inflammation and jumpstarting healing. In animal studies, it successfully treated heart attack damage and even showed promise for conditions like traumatic brain injury and pulmonary hypertension. Unlike earlier approaches that required direct injection into the heart, this new therapy can be delivered intravenously, allowing it to spread evenly and act quickly. Tue, 05 May 2026 14:20:47 EDT https://www.sciencedaily.com/releases/2026/05/260504211842.htm https://www.sciencedaily.com/releases/2026/05/260504154016.htm GLP-1 weight-loss drugs like Ozempic and Wegovy are often celebrated as game-changing solutions—but new research reveals a surprising social twist. People who lose weight using these medications may actually face more judgment than those who lose weight through diet and exercise—or even those who don’t lose weight at all. The stigma seems rooted in a perception that these drugs are an “easy way out,” creating a double bind where individuals are judged both for their weight and for how they choose to manage it. Tue, 05 May 2026 14:04:18 EDT https://www.sciencedaily.com/releases/2026/05/260504154016.htm https://www.sciencedaily.com/releases/2026/05/260504075512.htm A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of toxic amyloid proteins in the brain, a hallmark of the disease. In animal models, oral arginine not only lowered harmful protein deposits but also improved behavior and reduced brain inflammation. Mon, 04 May 2026 11:15:58 EDT https://www.sciencedaily.com/releases/2026/05/260504075512.htm https://www.sciencedaily.com/releases/2026/05/260504023828.htm Creatine might be famous in the gym, but its real story is far more interesting. Naturally produced in the body, it helps power cells by rapidly regenerating ATP—the fuel that keeps muscles, the brain, and even the heart running during intense activity. Supplementing with creatine can boost short bursts of physical performance and may even support memory, mood, and cognitive speed, especially in people with lower baseline levels. Mon, 04 May 2026 04:13:48 EDT https://www.sciencedaily.com/releases/2026/05/260504023828.htm https://www.sciencedaily.com/releases/2026/05/260502233924.htm GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and Wegovy—may also deliver a surprising mental health boost. In a massive study tracking nearly 100,000 people over more than a decade, researchers found that these medications were linked to significantly fewer psychiatric hospital visits and sick days. Mon, 04 May 2026 02:14:05 EDT https://www.sciencedaily.com/releases/2026/05/260502233924.htm https://www.sciencedaily.com/releases/2026/05/260501002156.htm Scientists have uncovered a surprising new layer of complexity in Cannabis, identifying dozens of previously unknown compounds—including the first-ever evidence of rare molecules called flavoalkaloids in its leaves. These compounds, prized for their potential health benefits, were hidden among a rich mix of plant chemicals that vary dramatically even between just a few strains. Fri, 01 May 2026 00:36:05 EDT https://www.sciencedaily.com/releases/2026/05/260501002156.htm https://www.sciencedaily.com/releases/2026/04/260430032411.htm A major review of 217 trials shows that aerobic exercise is the most effective option for managing knee osteoarthritis. Activities like walking, cycling, and swimming outperformed other exercise types in reducing pain and improving movement. While alternatives like strength training and mind-body exercises help, they are best used alongside aerobic workouts. The findings also confirm that exercise is a safe and essential part of treatment. Thu, 30 Apr 2026 03:30:17 EDT https://www.sciencedaily.com/releases/2026/04/260430032411.htm https://www.sciencedaily.com/releases/2026/04/260428045556.htm A decades-old drug once used to treat sleeping sickness is now showing surprising promise against an ultra-rare and life-threatening genetic disorder called Bachmann-Bupp syndrome (BABS). Early patient treatments suggest the drug, DFMO, may ease severe symptoms by targeting the underlying genetic malfunction. Researchers have already treated a handful of patients with encouraging results, but progress has been slowed by regulatory and logistical hurdles. Wed, 29 Apr 2026 01:28:38 EDT https://www.sciencedaily.com/releases/2026/04/260428045556.htm https://www.sciencedaily.com/releases/2026/04/260427050620.htm Researchers have found an enzyme that can turn fragile drug molecules into durable ring shapes. This could help medications like Ozempic last longer and work more effectively. The process is simpler and more precise than traditional methods, even for complex drugs. It may open the door to stronger, longer-lasting treatments. Tue, 28 Apr 2026 00:11:44 EDT https://www.sciencedaily.com/releases/2026/04/260427050620.htm https://www.sciencedaily.com/releases/2026/04/260426012317.htm Deep within the brain, scientists have uncovered a hidden “switch” that may decide whether pain fades away—or lingers for months or even years. Researchers found that a small, little-known region called the caudal granular insular cortex (CGIC) acts like a command center, telling the body to keep pain signals alive long after an injury has healed. In animal studies, shutting down this pathway not only prevented chronic pain from forming but could even erase it once it had taken hold. Mon, 27 Apr 2026 08:37:49 EDT https://www.sciencedaily.com/releases/2026/04/260426012317.htm https://www.sciencedaily.com/releases/2026/04/260425091216.htm A gut bacterium may be quietly fueling depression through an unexpected chemical twist. Researchers found that when Morganella morganii interacts with a common pollutant, it produces a molecule that triggers inflammation—something strongly linked to depression. This finding helps explain how gut microbes can influence brain health at a molecular level. It also raises the possibility of new treatments that target the immune system rather than just the brain. Sat, 25 Apr 2026 11:39:01 EDT https://www.sciencedaily.com/releases/2026/04/260425091216.htm https://www.sciencedaily.com/releases/2026/04/260424233210.htm Scientists have uncovered how graphene oxide pulls off a remarkable trick: it hunts down and destroys harmful bacteria while leaving human cells completely unharmed. By targeting a molecule found only in bacterial membranes, this ultra-thin carbon-based material acts with laser-like precision—offering a powerful new alternative to traditional antibiotics. Even more exciting, it works against drug-resistant “superbugs,” promotes faster wound healing, and keeps its antibacterial strength even after repeated washing. Sun, 26 Apr 2026 01:07:16 EDT https://www.sciencedaily.com/releases/2026/04/260424233210.htm